Although there was a trend to longer survival in mice bearing xenografts from newly diagnosed methylated tumors (Group I), the observed differences did not reach statistical significance, again suggesting that PARP inhibition may have a less profound effect on TMZ-sensitive tumors.
← all excerpts
ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.
1
—
—